SCHEMBL130541

SCHEMBL130541

CCCCCCCC/C=C/[O]

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.61
TRPV1 Q8NER1 1/20 0.61
FABP3 P05413 5/20 0.56
TSHR P16473 1/20 0.55
TERT O14746 2/20 0.52
GMNN O75496 1/20 0.52
USP2 O75604 1/20 0.52
LMNA P02545 1/20 0.52
CYP1A2 P05177 1/20 0.52
POLB P06746 1/20 0.52
MAPT P10636 1/20 0.52
CYP2C9 P11712 1/20 0.52
ALOX15 P16050 1/20 0.52
APEX1 P27695 1/20 0.52
CYP2C19 P33261 1/20 0.52
RECQL P46063 1/20 0.52
BLM P54132 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
HSD17B10 Q99714 1/20 0.52
DUSP3 P51452 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL449542 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL129255 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL131677 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL451503 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL450161 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL131304 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL449541 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL450162 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL449598 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT
SCHEMBL130013 1.00 FAAH (0.61) FAAHTRPV1FABP3TSHRTERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1137737-A1 LIQUID CRYSTAL COMPOUND Rolic AG (CH) 2001-10-04 EP claimed
WO-2000031211-A1 LIQUID CRYSTAL COMPOUND ROLIC AG (CH) 2000-06-02 WO claimed
US-11345914-B2 Composition for delivering nucleic acid and nucleic acid-containing composition TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES (JP) 2022-05-31 US disclosed
EP-3911698-A1 STABILIZER COMPOSITION FOR SEALANTS AND ADHESIVES BASF SE (DE) 2021-11-24 EP disclosed
CN-110062790-B Stabilizer composition 巴斯夫欧洲公司 2021-09-24 CN disclosed
CN-110062796-B Hardenable polymer composition 巴斯夫欧洲公司 2021-09-03 CN disclosed
CN-113302234-A Stabilizer composition for sealants and adhesives 巴斯夫欧洲公司 2021-08-24 CN disclosed
EP-3526288-B1 STABILIZER COMPOSITION BASF SE (DE) 2021-08-04 EP disclosed
EP-3526301-B1 HARDENABLE POLYMER COMPOSITION BASF SE (DE) 2021-06-16 EP disclosed
US-11001698-B2 Stabilizer composition BASF SE 2021-05-11 US disclosed
US-20210115440-A1 NUCLEIC ACID DELIVERY COMPOSITION, AND NUCLEIC ACID-CONTAINING COMPOSITION TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES (JP) 2021-04-22 US disclosed
US-4629581-A Cyclohexanecarbonitriles HOFFMANN-LA ROCHE INC. (US) 1986-12-16 US disclosed
EP-0200915-A1 Aminopropanol derivatives, process for their preparation, their use and medicines containing them Roche Diagnostics GmbH (DE) 1986-11-12 EP disclosed
US-4619794-A Spontaneous preparation of small unilamellar liposomes CIBA-GEIGY CORPORATION (US) 1986-10-28 US disclosed
EP-0172360-A2 Cyclohexanecarbonitriles and their use as components for liquid crystals F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1986-02-26 EP disclosed
EP-0168683-A2 Liquid crystals with alkenyl or alkenyloxy groups F. HOFFMANN-LA ROCHE AG (CH) 1986-01-22 EP disclosed
EP-0088046-A2 Lipids in the aqueous phase CIBA-GEIGY AG (CH) 1983-09-07 EP disclosed
EP-0071892-A2 Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-02-16 EP disclosed
EP-0004532-B1 1-ARYLOXY-3-NITRATOALKYLAMINO-2-PROPANOLS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS MERCK PATENT GmbH (DE) 1981-10-14 EP disclosed
EP-0004532-A1 1-Aryloxy-3-nitratoalkylamino-2-propanols, process for their preparation and pharmaceutical compositions MERCK PATENT GmbH (DE) 1979-10-17 EP disclosed